Today's Daily Dose brings you news about Co-Diagnostics securing FDA's Emergency Use Authorization for its SARS-CoV-2 diagnostic test; Immunomedics' ASCENT study; Millendo's disappointing Prader-Willi syndrome data; Menlo's failed Serlopitant trials; Mesoblast jumping into the COVID-19 drug development bandwagon and Vir Biotechnology's collaboration with GlaxoSmithKline to research and develop solutions for coronaviruses, including SARS-CoV-2.
Read on….
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com